$3.68
-0.07 (-1.87%)
K V Pharmaceutical Company (KV-A)
CAPS Rating:
Develops advanced drug delivery technologies which enhance the effectiveness of new therapeutic agents, existing pharmaceutical products and prescription nutritional products.

RSS Headlines
Fool UK
Recs
Expect EPS comps to look very good, and chart looks like it is ready for a run-up after fairly tight price range lt